Release Date: 17/01/22 08:20 Summary: Change of Director's Interest Notice x2 Price Sensitive: No Download Document 364.1KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%